Robert Glen Hart
#107,088
Most Influential Person Now
Robert Glen Hart's AcademicInfluence.com Rankings
Robert Glen Hartphilosophy Degrees
Philosophy
#4380
World Rank
#6869
Historical Rank
Logic
#1846
World Rank
#2699
Historical Rank
Robert Glen Hartmathematics Degrees
Mathematics
#5256
World Rank
#7411
Historical Rank
Statistics
#343
World Rank
#408
Historical Rank
Download Badge
Philosophy Mathematics
Robert Glen Hart's Degrees
- Doctorate Internal Medicine Stanford University
Why Is Robert Glen Hart Influential?
(Suggest an Edit or Addition)Robert Glen Hart's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation (2007) (4409)
- Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients (1994) (3667)
- Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. (1995) (2240)
- Apixaban in patients with atrial fibrillation. (2011) (1889)
- Effect of clopidogrel added to aspirin in patients with atrial fibrillation. (2009) (1867)
- Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease (2017) (1499)
- Guidelines for the Primary Prevention of Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association (2011) (1472)
- Embolic strokes of undetermined source: the case for a new clinical construct (2014) (1155)
- Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial (1996) (1081)
- Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). (2011) (786)
- Selecting Patients With Atrial Fibrillation for Anticoagulation: Stroke Risk Stratification in Patients Taking Aspirin (2004) (786)
- Antithrombotic therapy for atrial fibrillation (2002) (753)
- Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis. (2002) (752)
- Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators. (2000) (671)
- Management of patients with atrial fibrillation. A Statement for Healthcare Professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association. (1996) (643)
- Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators. (1992) (636)
- Cardiogenic brain embolism. The second report of the Cerebral Embolism Task Force. (1989) (612)
- Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial (2013) (583)
- Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source (2018) (579)
- Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. (2012) (572)
- Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators. (1999) (554)
- Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses. (1995) (540)
- Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Stroke Prevention in Atrial Fibrillation III Investigators. (1998) (518)
- Dissections of cervical and cerebral arteries. (1983) (431)
- Intracranial Hemorrhage in Atrial Fibrillation Patients During Anticoagulation With Warfarin or Dabigatran: The RE-LY Trial (2012) (409)
- Avoiding Central Nervous System Bleeding During Antithrombotic Therapy: Recent Data and Ideas (2005) (360)
- Embolic Stroke of Undetermined Source: A Systematic Review and Clinical Update (2017) (341)
- Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: I. Reduced flow velocity in the left atrial appendage (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study). (1999) (339)
- Effect of Age on Stroke Prevention Therapy in Patients With Atrial Fibrillation: The Atrial Fibrillation Investigators (2009) (330)
- Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke (2001) (328)
- Atrial fibrillation and stroke : concepts and controversies. (2001) (323)
- Predicting outcome from hypoxic-ischemic coma. (1985) (314)
- A patient decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation: a randomized controlled trial. (1999) (296)
- Prognostic Value of Plasma von Willebrand Factor and Soluble P-Selectin as Indices of Endothelial Damage and Platelet Activation in 994 Patients With Nonvalvular Atrial Fibrillation (2003) (293)
- Cerebral infarction in young adults: a practical approach. (1983) (284)
- Treatment of warfarin-associated intracerebral hemorrhage: literature review and expert opinion. (2007) (283)
- Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES. (2015) (276)
- Antiphospholipid antibodies and cerebral ischemia in young people (1990) (269)
- Immediate anticoagulation of embolic stroke: brain hemorrhage and management options. Cerebral Embolism Study Group. (1984) (265)
- Cardioembolic vs. Noncardioembolic Strokes in Atrial Fibrillation: Frequency and Effect of Antithrombotic Agents in the Stroke Prevention in Atrial Fibrillation Studies (2000) (260)
- Lessons from the Stroke Prevention in Atrial Fibrillation Trials (2003) (256)
- Abrupt Change in Head Position and Cerebral Infarction (1981) (253)
- Safety of Proton Pump Inhibitors Based on a Large, Multi-year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin. (2019) (249)
- Risks and Benefits of Oral Anticoagulation Compared With Clopidogrel Plus Aspirin in Patients With Atrial Fibrillation According to Stroke Risk: The Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE-W) (2008) (235)
- Stroke in infective endocarditis. (1990) (233)
- Atrial fibrillation and stroke: new ideas, persisting dilemmas. (1988) (219)
- Early recurrent embolism associated with nonvalvular atrial fibrillation: a retrospective study. (1983) (218)
- Recurrent brain hemorrhage is more frequent than ischemic stroke after intracranial hemorrhage (2001) (217)
- Irbesartan in patients with atrial fibrillation. (2011) (215)
- Hematologic disorders and ischemic stroke. A selective review. (1990) (206)
- National Stroke Association guidelines for the management of transient ischemic attacks (2006) (202)
- A clinical prediction rule to identify patients with atrial fibrillation and a low risk for stroke while taking aspirin. (2003) (202)
- Plasma von Willebrand Factor and Soluble P-Selectin as Indices of Endothelial Damage and Platelet Activation in 1321 Patients With Nonvalvular Atrial Fibrillation: Relationship to Stroke Risk Factors (2002) (201)
- High-Sensitivity C-Reactive Protein and Soluble CD40 Ligand as Indices of Inflammation and Platelet Activation in 880 Patients With Nonvalvular Atrial Fibrillation: Relationship to Stroke Risk Factors, Stroke Risk Stratification Schema, and Prognosis (2007) (192)
- Warfarin in atrial fibrillation patients with moderate chronic kidney disease. (2011) (190)
- Adjusted-dose warfarin versus aspirin for preventing stroke in patients with atrial fibrillation. (2007) (189)
- The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy. (2013) (178)
- Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial (2012) (176)
- Supplement to the Guidelines for the Management of Transient Ischemic Attacks A Statement From the Ad Hoc Committee on Guidelines for the Management of Transient Ischemic Attacks, Stroke Council, American Heart Association (1999) (174)
- Rationale and design of AVERROES: apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment. (2010) (173)
- Optimal INR for prevention of stroke and death in atrial fibrillation: a critical appraisal. (2006) (169)
- Mechanisms of intracranial hemorrhage in infective endocarditis. (1987) (165)
- Markers of thrombin and platelet activity in patients with atrial fibrillation: correlation with stroke among 1531 participants in the stroke prevention in atrial fibrillation III study. (1999) (164)
- Occurrence and Characteristics of Stroke Events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) Study (2005) (163)
- Aspirin for the primary prevention of stroke and other major vascular events: meta-analysis and hypotheses. (2000) (162)
- Occurrence and implications of seizures in subarachnoid hemorrhage due to ruptured intracranial aneurysms. (1981) (162)
- Ischemic stroke in patients with atrial fibrillation (1993) (161)
- Prevention of stroke in patients with nonvalvular atrial fibrillation (1998) (160)
- Additive Role of Plasma von Willebrand Factor Levels to Clinical Factors for Risk Stratification of Patients With Atrial Fibrillation (2006) (158)
- Left atrial diameter in nonvalvular atrial fibrillation: An echocardiographic study. Stroke Prevention in Atrial Fibrillation Investigators. (1999) (157)
- The Secondary Prevention of Small Subcortical Strokes (SPS3) Study (2011) (152)
- Increased Risk of Intracranial Hemorrhage when Aspirin Is Combined with Warfarin: A Meta-Analysis and Hypothesis (1999) (149)
- Neurologic complications of infective endocarditis (1991) (144)
- Cerebral Infarction Associated with Lupus Anticoagulants - Preliminary Report (1984) (143)
- Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial (2018) (136)
- Clinical and echocardiographic features of intermittent atrial fibrillation that predict recurrent atrial fibrillation (1995) (133)
- Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) Trial. (2017) (133)
- Net Clinical Benefit of Adding Clopidogrel to Aspirin Therapy in Patients With Atrial Fibrillation for Whom Vitamin K Antagonists Are Unsuitable (2011) (133)
- Stroke in the People's Republic of China. (1989) (132)
- Aortic plaque in atrial fibrillation: prevalence, predictors, and thromboembolic implications. (1999) (130)
- Recurrent Stroke With Rivaroxaban Compared With Aspirin According to Predictors of Atrial Fibrillation: Secondary Analysis of the NAVIGATE ESUS Randomized Clinical Trial. (2019) (123)
- Atrial Fibrillation, Stroke, and Acute Antithrombotic Therapy: Analysis of Randomized Clinical Trials (2002) (122)
- Guidelines for the management of transient ischemic attacks. From the Ad Hoc Committee on Guidelines for the Management of Transient Ischemic Attacks of the Stroke Council of the American Heart Association. (1994) (120)
- Atrial Fibrillation in Ischemic Stroke: Predicting Response to Thrombolysis and Clinical Outcomes (2013) (119)
- Epidemiologic features of asymptomatic cerebral infarction in patients with nonvalvular atrial fibrillation. (1990) (119)
- Design, Progress and Challenges of a Double-Blind Trial of Warfarin versus Aspirin for Symptomatic Intracranial Arterial Stenosis (2003) (116)
- Effects of long-term blood pressure lowering and dual antiplatelet treatment on cognitive function in patients with recent lacunar stroke: a secondary analysis from the SPS3 randomised trial (2014) (110)
- Multiple cerebral infarctions and dementia associated with anticardiolipin antibodies. (1987) (109)
- Stroke risk and efficacy of apixaban in atrial fibrillation patients with moderate chronic kidney disease. (2012) (109)
- Cognitive impairment in lacunar strokes: The SPS3 trial (2012) (107)
- Relationship between prothrombin activation fragment F1.2 and international normalized ratio in patients with atrial fibrillation. Stroke Prevention in Atrial Fibrillation Investigators. (1997) (107)
- Hemorrhagic infarcts. (1986) (105)
- Thyrotoxicosis, atrial fibrillation, and embolism, revisited. (1989) (105)
- Embolic strokes of undetermined source: Prevalence and patient features in the ESUS Global Registry (2016) (104)
- Assessment of three schemes for stratifying stroke risk in patients with nonvalvular atrial fibrillation. (2000) (104)
- Atrial Fibrillation and Cognitive Function: JACC Review Topic of the Week. (2019) (97)
- nonvalvular atrial fibrillation (2007) (96)
- Stroke in the TOTAL trial: a randomized trial of routine thrombectomy vs. percutaneous coronary intervention alone in ST elevation myocardial infarction. (2015) (94)
- Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) study. (2005) (93)
- Efficacy and safety of apixaban compared with aspirin in the elderly: a subgroup analysis from the AVERROES trial. (2016) (92)
- Bleeding During Treatment With Aspirin Versus Apixaban in Patients With Atrial Fibrillation Unsuitable for Warfarin: The Apixaban Versus Acetylsalicylic Acid to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin k Antagonist Treatment (AVERROES) Trial (2012) (91)
- Stroke prevention in atrial fibrillation patients with chronic kidney disease. (2013) (91)
- Atrial fibrillation and stroke. (1997) (91)
- Perindopril-Based Blood Pressure–Lowering Reduces Major Vascular Events in Patients With Atrial Fibrillation and Prior Stroke or Transient Ischemic Attack (2005) (89)
- Leave ‘em Alone – Why Continuous Variables Should Be Analyzed as Such (2008) (89)
- Rivaroxaban for secondary stroke prevention in patients with embolic strokes of undetermined source: Design of the NAVIGATE ESUS randomized trial (2016) (88)
- Vertebral artery dissection* (1988) (85)
- Transient Ischemic Attacks in Patients With Atrial Fibrillation: Implications for Secondary Prevention: The European Atrial Fibrillation Trial and Stroke Prevention in Atrial Fibrillation III Trial (2004) (81)
- Prosthetic valve endocarditis 1976-1987. Antibiotics, anticoagulation, and stroke. (1990) (80)
- Pantoprazole to Prevents Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-blind, Placebo-controlled Trial. (2019) (79)
- Anticoagulants in atrial fibrillation patients with chronic kidney disease (2012) (78)
- Primary Prevention of Ischemic Stroke (2006) (76)
- Neuroprotection trials in Parkinson's disease: Systematic review (2009) (76)
- Antithrombotic therapy for cerebrovascular disorders. An update. (1995) (75)
- Lacunar Strokes in Patients With Diabetes Mellitus: Risk Factors, Infarct Location, and Prognosis The Secondary Prevention of Small Subcortical Strokes Study (2014) (73)
- Current status of stroke risk stratification in patients with atrial fibrillation. (2009) (72)
- Balancing the benefits and risks of 2 doses of dabigatran compared with warfarin in atrial fibrillation. (2013) (68)
- Atrial fibrillation and stroke. Revisiting the dilemmas. (1994) (66)
- Hypoglycemic hemiplegia: two cases and a clinical review. (1987) (66)
- Carotid stenosis in patients with atrial fibrillation. Prevalence, risk factors, and relationship to stroke in the Stroke Prevention in Atrial Fibrillation Study. (1994) (65)
- Stroke Outcomes in the COMPASS Trial (2019) (65)
- Aspirin Dosage and Thromboxane Synthesis in Patients with Vascular Disease (2003) (64)
- Differential effect of aspirin versus warfarin on clinical stroke types in patients with atrial fibrillation (1996) (62)
- AHA Scientific Statement. Supplement to the guidelines for the management of transient ischemic attacks: A statement from the Ad Hoc Committee on Guidelines for the Management of Transient Ischemic Attacks, Stroke Council, American Heart Association. (1999) (61)
- Aspirin wars: the optimal dose of aspirin prevent stroke. (1996) (61)
- Clinical and echocardiographic features of intermittent atrial fibrillation that predict recurrent atrial fibrillation. Stroke Prevention in Atrial Fibrillation (SPAF) Investigators. (1995) (61)
- Efficacy and Safety of Rivaroxaban Versus Aspirin in Embolic Stroke of Undetermined Source and Carotid Atherosclerosis. (2019) (61)
- Mitral valve prolapse and cerebral infarction. (1982) (60)
- Achieved Blood Pressure and Outcomes in the Secondary Prevention of Small Subcortical Strokes Trial (2016) (60)
- Antithrombotic therapy for cerebrovascular disorders. (1989) (58)
- What causes intracerebral hemorrhage during warfarin therapy? (2000) (58)
- Management of cervical bruits and carotid stenosis in preoperative patients. (1983) (57)
- Albuminuria and the risk of incident stroke and stroke types in older adults (2010) (57)
- Global Survey of the Frequency of Atrial Fibrillation–Associated Stroke: Embolic Stroke of Undetermined Source Global Registry (2016) (56)
- Aortic Arch Atherosclerosis in Patients With Embolic Stroke of Undetermined Source: An Exploratory Analysis of the NAVIGATE ESUS Trial. (2019) (54)
- Predictors of stroke in patients paced for sick sinus syndrome. (2004) (54)
- Antithrombotic therapy in cerebrovascular disease. (1991) (53)
- Effect of apixaban on brain infarction and microbleeds: AVERROES-MRI assessment study. (2016) (50)
- The secondary prevention of stroke in patients with atrial fibrillation. (1986) (50)
- Assessment of anticoagulation intensity and management of bleeding with old and new oral anticoagulants. (2013) (49)
- Anticoagulation of embolic strokes of cardiac origin (1988) (48)
- Use of Warfarin at Discharge Among Acute Ischemic Stroke Patients With Nonvalvular Atrial Fibrillation in China (2016) (48)
- Neurologic manifestations of cardiogenic embolism: an update. (2002) (48)
- Epidemiologic features of asymptomatic cerebral infarction in patients with nonvalvular atrial fibrillation (1990) (48)
- Characterization of Patients with Embolic Strokes of Undetermined Source in the NAVIGATE ESUS Randomized Trial. (2018) (46)
- Association Between Low-Dose Rivaroxaban With or Without Aspirin and Ischemic Stroke Subtypes: A Secondary Analysis of the COMPASS Trial. (2020) (46)
- Global Survey of the Diagnostic Evaluation and Management of Cryptogenic Ischemic Stroke (2015) (45)
- An assessment of guidelines for prevention of ischemic stroke (2002) (44)
- Heparin anticoagulation in acute brain ischemia. (1988) (44)
- Diagnosis and management of ischemic stroke. Part II. Selected controversies. (1983) (43)
- Acute autonomic neuropathy. Two cases and a clinical review. (1990) (43)
- Embolic Stroke. (2017) (43)
- Primary Prevention Studies and the Healthy Elderly: Evaluating Barriers to Recruitment (2000) (42)
- Relationship Between Degree of Left Ventricular Dysfunction, Symptom Status, and Risk of Embolic Events in Patients With Atrial Fibrillation and Heart Failure (2015) (42)
- Aspirin use and incident stroke in the cardiovascular health study. CHS Collaborative Research Group. (1998) (41)
- Anticoagulation in Patients Aged ≥75 years with Atrial Fibrillation: Role of Novel Oral Anticoagulants (2013) (41)
- Effects of congestive heart failure on plasma von Willebrand factor and soluble P-selectin concentrations in patients with non-valvar atrial fibrillation (2005) (40)
- Effect of Addition of Clopidogrel to Aspirin on Mortality: Systematic Review of Randomized Trials (2012) (40)
- Asymptomatic carotid bruit and stenosis: a reappraisal. (1983) (40)
- Atrial fibrillation and stroke prevention. (2003) (39)
- Reliability and validity of blood pressure measurement in the Secondary Prevention of Small Subcortical Strokes study (2007) (39)
- Warfarin in atrial fibrillation: underused in the elderly, often inappropriately used in the young (1999) (38)
- Diagnosis and management of ischemic stroke. Part I.--Threatened stroke and its management. (1983) (38)
- Stroke risk in an elderly population with atrial fibrillation (1999) (37)
- Antiplatelet Therapy for Preventing Stroke in Patients With Nonvalvular Atrial Fibrillation and No Previous History of Stroke or Transient Ischemic Attacks (2006) (36)
- Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Stroke in Patients with a History of Atrial Fibrillation: Subgroup Analysis of the CHARISMA Randomized Trial (2008) (35)
- Stroke Outcomes in the Cardiovascular OutcoMes for People using Anticoagulation StrategieS (COMPASS) Trial (2018) (34)
- Anticoagulation in atrial fibrillation: selected controversies including optimal anticoagulation intensity, treatment of intracerebral hemorrhage (2008) (34)
- ABC of antithrombotic therapy: Antithrombotic therapy for atrial fibrillation (2002) (34)
- Aspirin therapy and risk of subdural hematoma: meta-analysis of randomized clinical trials. (2013) (33)
- Effect of Addition of Clopidogrel to Aspirin on Stroke Incidence: Meta-Analysis of Randomized Trials (2015) (33)
- Clinical features and racial/ethnic differences among the 3020 participants in the Secondary Prevention of Small Subcortical Strokes (SPS3) trial. (2013) (32)
- Antithrombotic therapy for atrial fibrillation. (2002) (32)
- Diagnosis of acoustic neuroma. (1981) (32)
- The CHA 2 DS 2-VASc score identifies those patients with atrial fibrillation and a CHADS 2 score of 1 who are unlikely to benefit from oral anticoagulant therapy (2012) (31)
- Potential Embolic Sources and Outcomes in Embolic Stroke of Undetermined Source in the NAVIGATE-ESUS Trial (2020) (31)
- Vitamin K Antagonists and Risk of Subdural Hematoma: Meta-Analysis of Randomized Clinical Trials (2014) (31)
- Antithrombotic therapies for stroke prevention (1994) (30)
- Antithrombotic therapy for cerebrovascular disorders. (1989) (30)
- Microbleeds in the Secondary Prevention of Small Subcortical Strokes Trial: Stroke, mortality, and treatment interactions (2017) (30)
- Antithrombotic therapy for cerebrovascular disorders (2002) (29)
- Characteristics of Recurrent Ischemic Stroke After Embolic Stroke of Undetermined Source: Secondary Analysis of a Randomized Clinical Trial. (2020) (29)
- Predictors of stroke recurrence in patients with recent lacunar stroke and response to interventions according to risk status: secondary prevention of small subcortical strokes trial. (2014) (29)
- Development of a decision aid for patients with atrial fibrillation who are considering antithrombotic therapy (2000) (28)
- Late-developing cerebral arteropathy after pyogenic meningitis. (2003) (28)
- ASA failure (2014) (27)
- Major Bleeding in Patients With Coronary or Peripheral Artery Disease Treated With Rivaroxaban Plus Aspirin. (2019) (26)
- Modification of Outcomes With Aspirin or Apixaban in Relation to CHADS2 and CHA2DS2-VASc Scores in Patients With Atrial Fibrillation: A Secondary Analysis of the AVERROES Study (2013) (26)
- Secondary Stroke Prevention in Cryptogenic Stroke and Embolic Stroke of Undetermined Source (ESUS) (2017) (26)
- The Role of Cardiovascular Implantable Electronic Devices in the Detection and Treatment of Subclinical Atrial Fibrillation: A Review (2017) (26)
- Carotid stenosis in patients with atrial fibrillation: Prevalence, risk factors, and relationship to stroke in the Stroke Prevention in Atrial Fibrillation study (1994) (25)
- Effect of Addition of Clopidogrel to Aspirin on Subdural Hematoma: Meta-Analysis of Randomized Clinical Trials (2015) (25)
- Clinical–MRI Correlations in a Multiethnic Cohort with Recent Lacunar Stroke: The SPS3 Trial (2014) (25)
- Mortality Benefit of Rivaroxaban Plus Aspirin in Patients With Chronic Coronary or Peripheral Artery Disease. (2021) (25)
- Aspirin Use and Incident Stroke in the Cardiovascular Health Study (1998) (24)
- Thromboembolism and antithrombotic therapy in cerebrovascular disease. (1986) (24)
- Predictors of Recurrent Ischemic Stroke in Patients with Embolic Strokes of Undetermined Source and Effects of Rivaroxaban Versus Aspirin According to Risk Status: The NAVIGATE ESUS Trial. (2019) (24)
- Bleeding and New Cancer Diagnosis in Patients with Atherosclerosis. (2019) (24)
- Carotid stenosis in patients with atrial fibrillation (1994) (24)
- Headache Improvement Through TMD Stabilization Appliance and Self-management Therapies (2006) (24)
- Clinical Correlates of Infarct Shape and Volume in Lacunar Strokes: The Secondary Prevention of Small Subcortical Strokes Trial (2014) (24)
- Atrial Cardiopathy and Nonstenosing Large Artery Plaque in Patients With Embolic Stroke of Undetermined Source (2020) (23)
- Stroke prevention in atrial fibrillation (2000) (23)
- Thrombolysis for acute stroke in hemodialysis: international survey of expert opinion. (2011) (23)
- Rapid Assessment and Treatment of Transient Ischemic Attacks and Minor Stroke in Canadian Emergency Departments: Time for a Paradigm Shift. (2015) (22)
- Fecal hemoglobin excretion in elderly patients with atrial fibrillation: combined aspirin and low-dose warfarin vs conventional warfarin therapy. (1996) (22)
- Stroke Prevention in Atrial Fibrillation: Looking Forward. (2018) (22)
- Neurologic disorders in a medical intensive care unit: A prospective survey (1989) (22)
- Microbleeds and the Effect of Anticoagulation in Patients With Embolic Stroke of Undetermined Source: An Exploratory Analysis of the NAVIGATE ESUS Randomized Clinical Trial. (2020) (21)
- Dabigatran Treatment of Acute Noncardioembolic Ischemic Stroke (2020) (21)
- Factor XIa inhibition with asundexian after acute non-cardioembolic ischaemic stroke (PACIFIC-Stroke): an international, randomised, double-blind, placebo-controlled, phase 2b trial (2022) (20)
- Stroke prevention in asymptomatic carotid artery disease: revascularization of carotid stenosis is not the solution. (2015) (20)
- Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source. (2018) (19)
- Sex, stroke, and atrial fibrillation. (2012) (19)
- Secondary prevention of small subcortical strokes (SPS3) (2003) (18)
- Duration of nonvalvular atrial fibrillation and stroke. (1983) (18)
- Seizure recurrence after a first, unprovoked seizure. (1986) (18)
- Frequency and features of embolic stroke of undetermined source in young adults (2018) (18)
- Branch atheromatous disease diagnosed as embolic stroke of undetermined source: A sub-analysis of NAVIGATE ESUS (2019) (18)
- Predictors of Mortality in Patients With Atrial Fibrillation (from the Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events [ACTIVE A]). (2017) (17)
- New Horizons in Pharmacologic Therapy for Secondary Stroke Prevention. (2020) (17)
- Rivaroxaban versus aspirin for secondary prevention of ischaemic stroke in patients with cancer: a subgroup analysis of the NAVIGATE ESUS randomized trial (2020) (16)
- Embolic strokes of undetermined source: support for a new clinical construct–Authors' reply (2014) (16)
- Non-vitamin K oral anticoagulants for secondary stroke prevention in patients with atrial fibrillation (2020) (16)
- Rationale and design of the Clarification of Optimal Anticoagulation through Genetics trial. (2013) (16)
- In vivo antithrombotic effect of aspirin: dose versus nongastrointestinal bleeding. (1993) (16)
- Should Patients With Ischemic Stroke or Transient Ischemic Attack With Atrial Fibrillation and Microbleeds Be Anticoagulated? (2017) (16)
- Vertebrobasilar ectasia in patients with lacunar stroke: the secondary prevention of small subcortical strokes trial. (2015) (16)
- Predictors of Mortality in Patients With Lacunar Stroke in the Secondary Prevention of Small Subcortical Strokes Trial (2014) (15)
- Who says “no” to participating in stroke clinical trials and why: an observational study from the Vancouver Stroke Program (2019) (15)
- Efficacy and Safety of Warfarin VS. Antiplatelet Therapy in Patients with Systolic Heart Failure and Sinus Rhythm: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (2014) (14)
- Development of a decision aid for atrial fibrillation who are considering antithrombotic therapy. (2000) (14)
- Modification of Outcomes With Aspirin or Apixaban in Relation to Female and Male Sex in Patients With Atrial Fibrillation: A Secondary Analysis of the AVERROES Study (2014) (14)
- Pseudotumor cerebri and facial pain. (1982) (13)
- Timing of Hemorrhagic Transformation of Cardioembolic Stroke Cerebral Embolism Study Group (1986) (13)
- Clinical Research in Primary Stroke Prevention: Needs, Opportunities, and Challenges (2005) (12)
- Cerebral mycotic aneurysms are rare in infective endocarditis (1990) (12)
- Dabigatran efficacy‐safety assessment for stroke prevention in patients with atrial fibrillation (2012) (12)
- Novel oral anticoagulants in secondary prevention of stroke. (2013) (12)
- Clinical Correlates of Infarct Shape and Volume in Lacunar Strokes The SPS3 Trial (2014) (12)
- Intracranial and systemic atherosclerosis in the NAVIGATE ESUS trial: Recurrent stroke risk and response to antithrombotic therapy. (2020) (12)
- Anticoagulation and embolic infarction (1983) (12)
- Data and safety monitoring in clinical research: a National Institute of Neurologic Disorders and Stroke perspective. (2005) (12)
- Survey of the causes of stroke among Mexican Americans in South Texas. (1998) (11)
- Abstract 150: Cerebral Microbleeds and Cognition in Lacunar Stroke Patients: The Secondary Prevention of Small Subcortical Strokes Trial (2018) (11)
- Are large simple trials for dementia prevention possible? (2019) (11)
- Ticlopidine hydrochloride use and threatened stroke. (1994) (11)
- Regarding article "Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association". (2011) (11)
- Stroke: part I. A clinical update on prevention. (1999) (11)
- Rationale, design, and baseline participant characteristics in the MRI and cognitive substudy of the cardiovascular outcomes for people using anticoagulation strategies trial (2018) (11)
- Hemorrhagic transformation of cardioembolic stroke. (1989) (11)
- Perindopril-based blood pressure lowering reduces major vascular events in patients with atrial fibrillation and prior stroke or TIA (130th American Neurological Association) (2005) (11)
- Anticoagulants in Patients with Atrial Fibrillation and End-Stage Renal Disease (2012) (11)
- Heart-brain interactions: neurocardiology or cardioneurology comes of age. (1987) (10)
- What's new in stroke? The top 10 studies of 2009-2011: part I. (2008) (10)
- Atrial size, atrial fibrillation, and stroke (1987) (9)
- Prevention and Treatment of Cardioembolic Stroke (1987) (9)
- The diagnosis of multiple sclerosis. (1982) (9)
- Evaluating Rates of Recurrent Ischemic Stroke Among Young Adults With Embolic Stroke of Undetermined Source: The Young ESUS Longitudinal Cohort Study. (2022) (8)
- What's new in stroke? (1995) (8)
- Oral anticoagulants vs. aspirin for stroke prevention in patients with non-valvular atrial fibrillation: the verdict is in. (2003) (8)
- Frequency and Patterns of Brain Infarction in Patients With Embolic Stroke of Undetermined Source: NAVIGATE ESUS Trial (2021) (8)
- Direct-acting oral anticoagulants: the brain gets a break. (2013) (8)
- Cognitive Performance following Lacunar Stroke in Spanish-Speaking Patients: Results from the SPS3 Trial (2015) (8)
- Relationship of plasma von Willebrand factor with stroke risk factors in 1,321 patients with Atrial Fibrillation (2002) (7)
- Stroke in young people--the heart of the matter. (1987) (7)
- Brain Hemorrhage in Embolic Stroke (1986) (7)
- Cardiogenic stroke. (1989) (7)
- Rivaroxaban for Prevention of Covert Brain Infarcts and Cognitive Decline (2020) (7)
- Antithrombotic therapy for stroke prevention in atrial fibrillation and mechanical heart valves (2012) (7)
- Do Current Guidelines Result in Overuse of Warfarin Anticoagulation in Patients With Atrial Fibrillation? (2009) (7)
- Hypercoagulability following coumadin withdrawal. (1983) (7)
- Predictors of lowering SBP to assigned targets at 12 months in the Secondary Prevention of Small Subcortical Strokes study (2012) (7)
- Differences in treatment preferences between persons who enrol and do not enrol in a clinical trial. (2001) (6)
- Safety of heparin in acute ischemic stroke (1996) (6)
- Anticoagulant therapy in acute brain ischaemia (2013) (6)
- What's new in stroke? The top 10 studies of 2006-2008. Part I. (2008) (6)
- Stroke prevention in older adults with atrial fibrillation (2013) (6)
- Antithrombotic Treatments for Stroke Prevention in Elderly Patients With Nonvalvular Atrial Fibrillation: Drugs and Doses. (2016) (6)
- Stroke Prevention Guidelines (1995) (6)
- A clinical prediction rule to identify patients with atrial fibrillation and a low risk for stroke while taking aspirin (2003) (6)
- Hemorrhagic infarction on CT in the absence of anticoagulation therapy. (1986) (5)
- Which Patients With Atrial Fibrillation and Chronic Kidney Disease Should Receive Anticoagulation-And With Which Anticoagulant? (2017) (5)
- Diagnosis of acoustic tumors (1984) (5)
- Age disparity in diagnostic evaluation of stroke patients: Embolic Stroke of Undetermined Source Global Registry Project (2016) (5)
- Aspirin in elderly atrial fibrillation patients. (1994) (5)
- Antihypertensives and Statin Therapy for Primary Stroke Prevention: A Secondary Analysis of the HOPE-3 Trial (2021) (5)
- A post hoc evaluation of a sample size re-estimation in the Secondary Prevention of Small Subcortical Strokes study (2016) (5)
- Review and update of the concept of embolic stroke of undetermined source (2022) (5)
- Spontaneous Temporary Remission in Primary Cns Lymphoma (1988) (5)
- Asymptomatic Carotid Artery Disease in Patients Undergoing Open Heart Surgery: A Neurologic Viewpoint (1987) (4)
- Interdisciplinary Council on Quality of Care and Outcomes Research Blood Pressure Research, and Council on Peripheral Vascular Disease, and Cardiovascular Nursing, Council on Epidemiology and Prevention, Council for High on behalf of the American Heart Association Stroke Council, Council on (2011) (4)
- What's new in stroke? The top 10 studies of 2006-2008. Part II. (2008) (4)
- Cerebral emboli of cardiac origin. (1985) (4)
- NAVIGATE ESUS: Phase-III RCT assessing prevention of stroke and systemic embolism in patients with embolic stroke of undetermined source (2015) (4)
- Functional Abilities of an International Post-Stroke Population: Standard Assessment of Global Everyday Activities (SAGEA) Scale. (2022) (4)
- Stroke in young adults: parasites and occult cardiac disease. (1983) (4)
- ASHP therapeutic position statement on antithrombotic therapy in chronic atrial fibrillation. American Society of Health-System Pharmacists. (1998) (4)
- European Stroke Council (2000) (4)
- Effect of Apixaban on All-Cause Mortality in Atrial Fibrillation: An Imputed Placebo Analysis (P5.003) (2014) (4)
- Intensity and quality of warfarin anticoagulation in Chinese patients: setting the record straight. (2015) (4)
- What's New in Stroke? The Top 10 for 2004/05 (2006) (4)
- Left Ventricular Geometry on Transthoracic Echocardiogram and Prognosis after Lacunar Stroke: The SPS3 Trial. (2015) (4)
- Applicability of NINDS-sponsored studies to community-based physician involvement (2008) (4)
- Rivaroxaban versus aspirin for prevention of covert brain infarcts in patients with embolic stroke of undetermined source: NAVIGATE ESUS MRI substudy (2021) (4)
- Cardiogenic stroke in the elderly. (1991) (3)
- Promoting Independent Mobility-related Physical ACTivity (IMPACT) in an inpatient stroke rehabilitation unit: a proof-of-concept evaluation of self-management intervention (2020) (3)
- Oral Anticoagulants for Secondary Prevention of Stroke (1997) (3)
- Abstract WP187: Correlation between Infarct Shape and Volume and Ischemic Risk Factors and Recurrent Ischemic Rates in Small Subcortical Stroke; Data from the SPS3 Randomized Controlled Trial (2013) (3)
- Cerebral embolism. (1986) (3)
- Do we really need a better way to give heparin in acute cerebral ischemia? (2002) (3)
- What's new in stroke? The top 10 studies of 2009-2011: part II. (2011) (3)
- Prevention and Treatment of Venous Thromboembolism in Patients with Acute Intracerebral Hemorrhage (2005) (3)
- Making anticoagulation safer. (2002) (3)
- Stroke and the total artificial heart: neurologic considerations. (1987) (3)
- Cerebral ischemia and atrial fibrillation (1985) (3)
- Vorapaxar, combination antiplatelet therapy, and stroke. (2014) (3)
- Stroke prevention in atrial fibrillation: Commentary regarding the AAN's evidence-based guideline update. (2014) (3)
- THE CHA2DS2-VASC SCORE IDENTIFIES AF PATIENTS WITH A CHADS2 SCORE OF 0 OR 1 TREATED WITH ANTIPLATELET THERAPY WHO ARE UNLIKELY TO BENEFIT FROM ORAL ANTICOAGULANT THERAPY (2012) (2)
- Anticoagulation therapy for patients with atrial fibrillation. (2000) (2)
- Oral anticoagulation versus antiplatelet therapy for secondary stroke prevention in patients with embolic stroke of undetermined source: A systematic review and meta-analysis (2022) (2)
- Epidural Hematoma and Hemorrhagic Infarction Mimicking a Left Temporal Meningioma (1999) (2)
- Antithrombotic therapies for stroke prevention: Perspectives and prejudices (2003) (2)
- Warfarin for prevention of stroke: A practical, clinical review (1996) (2)
- Warfarin and low-dose aspirin for stroke prevention from severe intracranial stenosis. (1999) (2)
- Abstract 66: MRI Predictors of Stroke Recurrence in Patients With Recent Lacunar Stroke: The SPS3 Trial (2014) (2)
- Why Is WASID an Important Clinical Trial? (2003) (2)
- Regional, sex, and age differences in diagnostic testing among participants in the NAVIGATE-ESUS trial (2019) (2)
- Serum potassium level and dietary potassium intake as risk factors for stroke (2003) (2)
- Reducing the risk of recurrent stroke in patients with AF (2012) (2)
- Frequency and Predictors of Major Bleeding in Patients With Embolic Strokes of Undetermined Source (2020) (2)
- Thromboembolism in Nonrheumatic Atrial Fibrillation: What Have We Learned? (1992) (2)
- Mitral valve prolapse and embolic stroke. (1985) (2)
- Rapid reversal of haematoma expansion associated with vitamin K antagonists (2016) (2)
- Stroke Epidemiology, Etiology, and Background (2014) (2)
- Budgets for clinical trials. (2009) (2)
- Antithrombotic therapies for stroke prevention in atrial fibrillation. (2003) (2)
- Symptomatology and Diagnosis of Multiple Sclerosis-Reply (1982) (2)
- Heparin in acute stroke. (1989) (2)
- Rationale , Design and Baseline Characteristics of Participants in the C ardiovascular O utco m es for P eople Using A nticoagulation S trategie s ( COMPASS ) Trial (2017) (2)
- Randomized Controlled Trial Therapy for Stroke Prevention in Atrial Fibrillation : A A Patient Decision Aid Regarding Antithrombotic (1999) (2)
- Abstract 11087: Benefits of Dabigatran versus Warfarin in Hypertensive Patients With Atrial Fibrillation: Results From The Re-ly Trial (2013) (2)
- Abstract 213: Cerebral Microbleeds in 1278 Lacunar Stroke Patients: The Secondary Prevention of Small Subcortical Strokes (SPS3) Trial (2015) (1)
- Is There a Role for Betrixaban to Prevent Stroke in Medically Ill Patients? (2017) (1)
- Rivaroxaban versus aspirin on functional and cognitive outcomes after embolic stroke of undetermined source: NAVIGATE ESUS trial. (2022) (1)
- Abstract 14433: Balancing the Benefits and Risks of Two Doses of Dabigatran Compared with Warfarin in Atrial Fibrillation (2012) (1)
- Abstract TP222: Frequency of Intracranial Arterial Imaging and its Yield in Consecutive Patients with Non-lacunar Cryptogenic Ischemic Stroke: ESUS Global Registry (2016) (1)
- OE-144 Perindopril-based Blood Pressure lowering Reduces Major Vascular Events in Patients with Atrial Fibrillation and Prior Stroke or Transient Ischaemic Attack(Preventive medicine/Epidemiology/Education-1 (H) OE24,Oral Presentation (English),The 70th Anniversary Annual Scientific Meeting of the J (2006) (1)
- Effects of long-term blood pressure lowering and dual antiplatelet therapy on cognition in patients with recent lacunar stroke : Secondary Prevention of Small Subcortical Strokes ( SPS 3 ) trial The SPS 3 Investigators * (2015) (1)
- Did we really need another comparison of warfarin with aspirin? An assessment of the BAFTA trial. (2007) (1)
- BLEEDING WITH ASPIRIN AND APIXABAN IN PATIENTS UNSUITABLE FOR VITAMIN K ANTAGONIST THERAPY: THE AVERROES STUDY (2012) (1)
- Abstract TMP117: Characterization of Patients With Embolic Strokes of Uncertain Source in the Navigate-ESUS Trial (2018) (1)
- Aspirin Use and Risk of Subdural Hematoma: Updated Meta-Analysis of Randomized Trials. (2021) (1)
- Atrial fibrillation and stroke: Four treatment controversies (2005) (1)
- Abstract TMP75: Atrial Fibrillation In Ischemic Stroke: Predicting Response To Thrombolysis And Clinical Outcomes (2013) (1)
- Anticoagulation for nonrheumatic atrial fibrillation. (1997) (1)
- Abstract 95: The impact of Blood Pressure Variability on Stroke Recurrence: The SPS3 trial (2014) (1)
- Oral anticoagulants versus antiplatelet therapy for preventing stroke and systemic embolic events in patients with atrial fibrillation (2012) (1)
- Oral factor Xa inhibitors and risk of subdural hematoma (2020) (1)
- What's New in Stroke? Phase III Randomized Clinical Trials of 2012–2014 (2015) (1)
- Abstract 15542: Impact of Treatment with Apixaban and Aspirin in Patients with Atrial Fibrillation in Relation to the CHADS2 and CHA2DS2-VASc Scores: the AVERROES Study (2011) (1)
- Intracranial Atherosclerotic Plaque and Embolic Stroke of Undetermined Source: Another Piece of the Puzzle. (2021) (1)
- Professionals From the American Heart Association/American Stroke Association Guidelines for the Primary Prevention of Stroke : A Guideline for Healthcare (2012) (1)
- Abstract 209: Intracranial Wall Irregularity and Recurrent Stroke: the SPS3 Trial (2015) (0)
- Secondary Prevention of Stroke in Patients with Atrial Fibrillation: What Every Neurologist Should Know (2003) (0)
- IN VIVO ANTITHROMBOTIC EFFECT OF ASPIRIN : DOSE VERSUS NONGASTROINTESTINALBLEEDING. AUTHOR'S REPLIES (1993) (0)
- Cholesterol lowering and the risk of stroke. (1996) (0)
- Abstract 3776: Apixaban Compared To Aspirin In Patients With Atrial Fibrillation And Prior Transient Ischemic Attack Or Stroke: Results Of A Predefined Subgroup Analysis From Averroes (2012) (0)
- Stroke prevention essentials. (2001) (0)
- Abstract WMP104: Effect Of Addition Of Clopidogrel To Aspirin On Stroke Incidence: Meta-analysis Of Randomized Trials (2013) (0)
- Abnormal Left Ventricular Geometry in Lacunar Stroke: Spectrum, Prevalence and Prognostic Implications in the SPS3 Trial (S15.001) (2014) (0)
- Abstract TP197: Early Direct Oral Anticoagulants Therapy After Ischemic Stroke In Patients With And Without Atrial Fibrillation:A Pooled Analysis Of Five Studies (2022) (0)
- Dabigatran Treatment of Acute Non-Cardioembolic Ischaemic Stroke: A Randomised Controlled Trial (2019) (0)
- P-253: Lack of an independent effect of blood pressure on the hypercoagulable state in 1338 patients with atrial fibrillation (2002) (0)
- Interdisciplinary Council on Quali Blood Pressure Research, Council on Peripheral Vascular Disease, and Cardiovascular Nursing, Council on Epidemiology and Prevention, Council for High and on behalf of the American Heart Association Stroke Council, Council on (2010) (0)
- Infarct shape and volume in recent lacunar stroke 3 (2014) (0)
- Cardioembolic Stroke Workshop Discussion of Abstracts (Chairmen’s Synopsis) (1986) (0)
- The Effect of Blood Pressure on Plasma Levels of von Willebrand factor and Soluble P-Selectin in Patients with Atrial Fibrillation (2002) (0)
- Trigeminal neuralgia and other facial pains. (1981) (0)
- Abstract 104: First Stroke Reduced 44 Percent by Well Tolerated Medications. Stroke Outcomes From the Heart Outcomes Prevention Evaluation 3 Study (2018) (0)
- Abstract WP177: Effects Of The Oral Factor XIa Inhibitor Asundexian On Intracranial Bleeding Among Patients With Acute Non-Cardioembolic Ischemic Stroke: PACIFIC-Stroke Randomized Trial (2023) (0)
- Final Study Report of Andexanet Alfa for Major Bleeding With Factor Xa Inhibitors (2023) (0)
- Carotid-artery stenting versus endarterectomy. (2005) (0)
- Are Factor Xa Inhibitors Efficacious for Ischemic Stroke Prevention in Patients without Atrial Fibrillation? Evidence from Randomized Clinical Trials. (2022) (0)
- Stroke and Atrial Fibrillation (2019) (0)
- Abstract WP166: Prediction of Recurrent Stroke in Lacunar Stroke Patients: Performance of the Small Vessel Disease (SVD) Score in the SPS3 Trial (2016) (0)
- Anticoagulation in CKD (2015) (0)
- ASPIRIN FOR ASYMPTOMATIC CAROTID ARTERY STENOSIS. AUTHORS' REPLY (1996) (0)
- Warfarin-Related Intracerebral Hemorrhage: Predictors of Hematoma Expansion and In-Hospital Mortality (P6.055) (2016) (0)
- Atrial Fibrillation and Stroke Concepts and Controversies Comments, Opinions, and Reviews (2001) (0)
- What's new in stroke? (1998) (0)
- Transient Ischemic Attacks, Stroke Council, American Heart Association of : A Statement From the Ad Hoc Committee on Guidelines for the Management Supplement to the Guidelines for the Management of Transient Ischemic Attacks (2010) (0)
- 193 – Management of Atrial Fibrillation (1997) (0)
- Cholesterol Lowering and the Risk of Stroke (1996) (0)
- A Selective Review (2005) (0)
- Early Termination of the Stroke Prevention in Atrial Fibrillation I Trial: Protecting Participant Interests in the Face of Scientific Uncertainties and the Cruel Play of Chance (2006) (0)
- Aspirin for the Primary Prevention of Stroke and Other Major Vascular Events (2017) (0)
- Cooling of children with severe traumatic brain injury (2013) (0)
- Ischemic Attacks Addendum to the Supplement to the Guidelines for the Management of Transient (2010) (0)
- Abstract 41: Cerebral Microbleeds and the Effect of Anticoagulation on Outcomes in 3699 Patients With Embolic Strokes of Undetermined Source: An Exploratory Analysis of the NAVIGATE ESUS Trial (2019) (0)
- Abstract 137: Noninvasive Fractional Flow on MRA and Recurrent Stroke: SPS3 Trial (2015) (0)
- Clopidogrel in Atrial Fibrillation: Is There Any Justification Now in the Era of New Anticoagulants? (2012) (0)
- Abstract 21: Effect of Oral Factor Xa Inhibitors on the Risk of Subdural Hematoma: COMPASS trial Results and Systematic Review (2019) (0)
- Cardioembolic Stroke: Concepts and Controversies (1986) (0)
- Ischemic Attacks , Stroke Council , American Heart Association Statement From the Ad Hoc Committee on Guidelines for the Management of Transient Supplement to the Guidelines for the Management of Transient Ischemic Attacks : A Print (1999) (0)
- Comments, Opinions, and Reviews Stroke in the People's Republic of China (2005) (0)
- most patients in stroke rehab are not eligible for independent walking interventions: Lessons from the Impact walking study : o2.7 (2015) (0)
- Aspirin for Asymptomatic Carotid Artery Stenosis (1996) (0)
- Atrial Fibrillation and Prevention of Embolic Stroke: Personal Reflections. (2021) (0)
- Abstract TP207: Baseline Characteristics And Functional Outcomes Of Pontine And Non-pontine Infarcts: On Behalf Of The Secondary Prevention Of Small Subcortical Strokes (SPS3) Investigators (2013) (0)
- Secondary pre v in patients with a (2003) (0)
- Arrogance revisited. (1989) (0)
- Frequency and Features of Patients with Embolic Stroke of Undetermined Source(ESUS) (2014) (0)
- Clinical Risk of Stroke in Atrial Fibrillation is Unrelated to Platelet Activation (2002) (0)
- Event Adjudication Changes Key Results in Open-Label Trials: The AFFIRM Experience (2010) (0)
- Abstract TP380: Increasing the Sample Size in the Secondary Prevention of Small Subcortical Strokes (SPS3) Trial: What Did We Gain? (2013) (0)
- The Unmet Need of Patients with Atrial Fibrillation: AVERROES and the Novel Oral Anticoagulants (2011) (0)
- Anticoagulation intensity and stroke during warfarin-use in atrial fibrillation patients. (2006) (0)
- predicted by "unmasking" of persistent risk factors. The overall clinical importance of this effect is uncertain. (1983) (0)
- Antithrombotic therapy for cerebrovascular disease. Prevention and treatment of stroke. (1986) (0)
- Is low-dose aspirin a safe and effective option for primary stroke prevention in patients with atrial fibrillation? (2006) (0)
- Secondary prev in patients with a (2003) (0)
- Anticoagulation of embolic strokes (1988) (0)
- Abstract TMP117: Intracranial Dolichoectasia in Patients with Lacunar Strokes: The SPS3 Trial (2013) (0)
- Left Atrial Enlargement Could Be Detected on Extended Computed Tomography Angiography Within Initial Stroke Assessment-Reply. (2019) (0)
- Should Blood Pressure Targets After Lacunar Stroke Vary by Body Size? The SPS3 Trial. (2015) (0)
- Stroke: How good is aspirin for patients with acute brain ischaemia? (2016) (0)
- Two Cases and a Clinical Review (2016) (0)
- Unmasking the benefits of B vitamins in stroke prevention (2016) (0)
- Randomized clinical trials of antithrombotic therapy in atrial fibrillation: Update 2003 (2003) (0)
- SAFETY OF HEPARIN IN ACUTE ISCHEMIC STROKE. AUTHORS' REPLY (1996) (0)
- Early recurrent embolism in rheumatic heart disease. (1985) (0)
- Abstract 168: Prevalence And Characterization Of Neuropsychological Deficits In Lacunar Stroke Patients. The Secondary Prevention Of Small Subcortical Strokes (sps3) Trial (2012) (0)
- Antithrombotic Therapy for Cerebrovascu lar Disorders (2015) (0)
- Analysis of findings on cranial magnetic resonance imaging (MRI) on the first 900 participants in the secondary prevention of small subcortical strokes (SPS3) trial (2010) (0)
- Prevention of stroke in atrial fibrillation: an update. (1994) (0)
- Abstract WP203: Effects Of Oral Factor Xa Inhibitors On Ischemic Stroke In Patients Without Atrial Fibrillation: Systematic Review Of Randomized Clinical Trials (2022) (0)
- Abstract T MP53: Frequency Aad Features of Patients With Embolic Strokes of Underdetermined Source (esus): Esus Global Registry (2015) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Robert Glen Hart?
Robert Glen Hart is affiliated with the following schools:
